New Leukemia Drug Stems From Feverfew
A new, easily ingested form of a compound that has already shown it can attack the roots of leukemia in laboratory studies is moving into human clinical trials, according to a new article by University of Rochester investigators in the journal, Blood.The Rochester team has been leading the investigation of this promising therapy on the deadly blood cancer for nearly five years.
